Information Quality Assurance Act of 2025

The Information Quality Assurance Act of 2025 (HR6329) was introduced in the House on December 1, 2025, and has been referred to the Committees on Oversight and Government Reform and the Judiciary. The bill aims to ensure federal agencies rely on the best reasonably available scientific, technical, demographic, economic, and statistical information and evidence. On February 23, 2026, the House considered the bill under suspension of the rules and proceeded with debate, but further proceedings were postponed. This indicates active legislative consideration, though it remains in an early stage. This bill does not authorize or appropriate specific funding amounts. Instead, it mandates a change in federal agency operations by requiring the Office of Management and Budget to update guidelines for federal agencies regarding the dissemination and use of influential information. This regulatory change would create demand for services related to information management, data quality, and compliance, which federal agencies would need to procure from external vendors or develop internally. The financial impact on companies would stem from increased contract opportunities for these services, rather than direct government funding allocations. Technology companies specializing in data management, analytics, and consulting services are structurally positioned to benefit from such mandates. These include companies like $IBM, $ACN, $MSTR, and $ORCL. Their business models align with providing the expertise and technology required for federal agencies to meet enhanced data quality standards. There are no direct losers identified by this bill, as it focuses on improving government operations rather than restricting specific industries. Regarding recent market performance, $IBM is currently trading at $243.2, showing a 7-day gain of +0.33% but a 30-day decline of -6.05%. $ACN is at $197.03, with a 7-day decline of -0.64% and a 30-day decline of -8.36%. $MSTR is at $126, reflecting a 7-day gain of +0.96% but a 30-day decline of -5.64%. $ORCL is at $143.33, experiencing a 7-day decline of -2.57% and a 30-day decline of -6.3%. All four companies have experienced 30-day declines, indicating broader market or sector pressures unrelated to this specific legislative event. The bill is in an early legislative stage, having been referred to committee and debated under suspension of the rules. It still needs to pass both the House and Senate and be signed into law to take effect. The next steps would involve committee review and potential votes in the House. Rep. McClain (R-MI-9) is the sponsor, with one cosponsor. The bill has been referred to three committees, indicating multiple jurisdictions are involved. The action history shows recent debate in the House on February 23, 2026, following committee consideration and ordering to be reported (amended) on December 2, 2025. This suggests some momentum, but the bill has not yet passed the House.